Omoconazole
Omoconazole is an imidazole-derived azole antifungal agent. Omoconazole exhibits broad-spectrum in vitro activity against dermatophytes, yeasts, and dimorphic fungi, exerting fungistatic effects at low concentrations and fungicidal effects at high concentrations. Omoconazole accumulates in the skin, binds to keratin, and is slowly transferred from the stratum corneum to the viable epidermis. Omoconazole inhibits the growth of dermatophytes, impairs daughter cell separation in Candida albicans, induces cell wall thickening, disrupts intracellular cytoplasmic organelles, and leads to cell death. Omoconazole is used in studies related to dermatophytosis and superficial fungal infections.
For research use only. We do not sell to patients.
- CAS No.: 74512-12-2
- Formula: C20H17Cl3N2O2
- Molecular Weight:423.72
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Omoconazole (0.4-40 μg/mL; 8-24 h) induces concentration- and time-dependent morphological and ultrastructural changes in Candida albicans TIMM 0146, exerting a fungistatic effect at medium and low concentrations (characterized by cell aggregation, cell wall thickening, and Golgi-like structure formation) and a fungicidal effect at high concentrations (characterized by organelle destruction and cytolysis)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Hartley (female, 300-350 g, dermatophytosis model via Trichophyton mentagrophytes conidial suspension inoculation on abraded shaved back skin)[1]
-
Dosage:0.25% cream; 0.5% cream; 1.0% cream; 2.0% cream
-
Administration:topical; once daily; 14 days
-
Result:Significantly reduced lesional symptoms starting on days 8-10 post-infection with all tested concentrations.
Achieved almost complete symptomatological cure with 1.0% and 2.0% creams by the end of 14-day treatment.
Resulted in a mean of 8.3 culture-positive skin blocks in 0.25% cream-treated animals.
Resulted in a mean of 1.5 culture-positive skin blocks in 0.5% cream-treated animals.
Resulted in 0 culture-positive skin blocks in 1.0% and 2.0% cream-treated animals, indicating complete inhibition of fungal growth.
Chemical Information
-
CAS No. 74512-12-2
-
Molecular Weight 423.72
-
Formula C20H17Cl3N2O2
-
SMILES
C/C(N1C=CN=C1)=C(C2=C(C=C(C=C2)Cl)Cl)/OCCOC3=CC=C(C=C3)Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Immunoaffinity-Based Positive/Negative Selection Without Magnetic or Flow Cytometric Separation
Immunoaffinity-based positive/negative selection without magnetic or flow cytometric separation is implemented as immunopanning, in which dissociated cells bind to antibody-coated plastic surfaces through specific cell-surface antigens; negative-selection plates remove unwanted antigen-positive cells, and positive-selection plates retain the desired antigen-positive population for recovery and downstream culture or analysis. The readout is the recovered cell fraction after sequential plate binding and washing: depleted non-adherent cells represent the negative-selection output, while cells retained on the final antibody-coated surface represent the positive-selection output; published examples include T-cell subpopulation purification, mouse and rat oligodendrocyte-lineage cell isolation, and mouse marrow progenitor enrichment.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Density Gradient Centrifugation-Based Cell Fractionation (Cell Enrichment Sorting)
Density gradient centrifugation enriches cells by buoyant density: cells sediment during centrifugation until they reach a medium layer or interface compatible with their density, allowing mononuclear cells, granulocytes, erythrocytes, and density-defined subpopulations to be recovered from separate bands or layers. Classic blood-cell applications include Ficoll/sodium-metrizoate or Ficoll-Hypaque enrichment of peripheral blood mononuclear cells, Percoll subfractionation of PBMC and T-cell populations, and Percoll-based neutrophil isolation from whole blood or leukocyte-enriched suspensions. The readout is the physical recovery of enriched cell bands, followed by cell counting, morphology, viability, and immunophenotyping to determine yield, purity, and suitability for downstream assays.
-
Microfluidic Cell Sorting (Label-Free and Affinity-Based Platforms)
Microfluidic cell sorting separates target cells in microscale channels by either intrinsic physical properties or specific molecular binding. Label-free platforms use size, deformability, hydrodynamic behavior, acoustic contrast, dielectric properties, or inertial migration to alter cell trajectories without antibody labeling, while affinity-based platforms immobilize antibodies, selectins, aptamers, or ligand-bearing nanoparticles to capture cells expressing corresponding surface markers. Classic label-free examples include deterministic lateral displacement arrays, inertial focusing systems, acoustophoresis devices, dielectrophoresis systems, and physical cluster-capture devices. Classic affinity-based examples include EpCAM-coated micropost or herringbone chips, PSMA-GEDI devices, E-selectin/anti-EpCAM biomimetic surfaces, and nanoparticle-mediated capture-and-release chips.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Dielectrophoresis (DEP)-Based Electrical Cell Sorting
Dielectrophoresis-based electrical cell sorting separates suspended cells by the motion generated when polarizable cells experience a non-uniform electric field; cell trajectory depends on cell size, medium conductivity, applied AC frequency, electric-field gradient, and cell dielectric properties, so cells with different DEP responses can be routed, trapped, levitated, or released without biochemical labeling. In practical DEP sorters, the readout is the spatial redistribution of cells into different outlets, traps, or recovered fractions; reported examples include DEP field-flow fractionation of leukocytes, breast cancer cells, CD34+ cells, and blood cells, continuous-flow hMSC/osteoblast sorting, and image-based single-cell recovery after DEP manipulation.
-
Magnetic-Activated Cell Sorting (MACS)-Based Enrichment and Separation
MACS enriches or depletes cells by binding antibody-targeted magnetic particles to surface antigens; labeled cells are retained in a high-gradient magnetic column, while unlabeled cells pass through, and retained cells are eluted after removal from the magnetic field. In ovalbumin-induced allergic airway inflammation, MACS can enrich immune populations such as CD4+ T cells, CD8+ T cells, dendritic cells, eosinophils, or marker-defined leukocytes for downstream analysis of airway inflammation, antigen presentation, and type 2 immune responses.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)